| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.0064 | 1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.0091 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.0067 | 1 |